Teachers Advisors’s Tvardi Therapeutics TVRD Stock Holding History

Teachers Advisors’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.32M	Hold	1,863	–	–	﹤0.01%	2172
2018 Q4	$872K	Buy	1,863 +106	+6%	+$68.4K	﹤0.01%	2257
2018 Q3	$1.51M	Buy	1,757 +235	+15%	+$170K	﹤0.01%	2116
2018 Q2	$1.05M	Buy	1,522 +123	+9%	+$62.5K	﹤0.01%	2307
2018 Q1	$624K	Hold	1,399	–	–	﹤0.01%	2429
2017 Q4	$617K	Hold	1,399	–	–	﹤0.01%	2473
2017 Q3	$690K	Buy	1,399 +54	+4%	+$27K	﹤0.01%	2437
2017 Q2	$745K	Buy	1,345 +250	+23%	+$159K	﹤0.01%	2401
2017 Q1	$725K	Buy	1,095 +167	+18%	+$89.2K	﹤0.01%	2339
2016 Q4	$310K	Buy	928 +71	+8%	+$22.8K	﹤0.01%	2760
2016 Q3	$257K	Hold	857	–	–	﹤0.01%	2776
2016 Q2	$148K	Buy	857 +3	+0.4%	+$653	﹤0.01%	2985
2016 Q1	$191K	Sell	854 -3,378	-80%	-$1.01M	﹤0.01%	2804
2015 Q4	$2.57M	Buy	4,232 +115	+3%	+$63.1K	﹤0.01%	1447
2015 Q3	$2.12M	Buy	4,117 +59	+1%	+$39.5K	﹤0.01%	1548
2015 Q2	$1.77M	Buy	4,058 +797	+24%	+$308K	﹤0.01%	1767
2015 Q1	$1.18M	Hold	3,261	–	–	﹤0.01%	1961
2014 Q4	$1.17M	Hold	3,261	–	–	﹤0.01%	1948
2014 Q3	$985K	Hold	3,261	–	–	﹤0.01%	2018
2014 Q2	$2M	Buy	3,261 +2,941	+919%	+$1.58M	﹤0.01%	1623
2014 Q1	$215K	Buy	+320	New	+$189K	﹤0.01%	2844

Other funds holding TVRD

RCP

Rho Capital Partners New York $20.4M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Teachers Advisors's TVRD Position: Q1 2019 in Review

Teachers Advisors held its Tvardi Therapeutics (TVRD) position steady in Q1 2019 at 1,863 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Teachers Advisors first reported a position in TVRD in Q1 2014 and has held it in 21 quarters since. The position peaked at $2.57M in Q4 2015. 135 funds tracked by Wall St. Rank hold TVRD as of Q1 2019.

Teachers Advisors held 1,863 shares of Tvardi Therapeutics worth $1.32M as of Q1 2019.
Teachers Advisors left its Tvardi Therapeutics share count unchanged in Q1 2019.
Tvardi Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2172 holding.
Teachers Advisors first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 21 quarters since.
Teachers Advisors's Tvardi Therapeutics position peaked at $2.57M in Q4 2015.
135 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.